The J. Craig Venter Institute spun out Diploid Genomics with seed investment from Healthier Capital to build an AI‑driven genomics analytics and diagnostics platform. Founders include Craig Venter, Gene Myers and Anders Dale; the company plans a San Diego sequencing center and aims for CLIA certification to deliver clinical‑grade, AI‑enhanced genomic interpretation for research and diagnostics. Diploid positions itself to combine long‑read sequencing (PacBio, ONT) with imaging and clinical data for complex disease diagnostics. The venture highlights continued consolidation of AI, sequencing and clinical data into commercial diagnostic offerings and signals renewed industry focus on end‑to‑end genomics services.